发明名称 |
Treatment of cancer by the administration of fas ligand expressing non-tumorigenic cells |
摘要 |
The present invention provides a method of treating solid tumors wherein the cells of the tumor express the Fas receptor. The method comprises administering to the tumor cells non-tumorigenic cells which express the Fas ligand. The non-tumorigenic cells can be myoblasts which may be a naturally Fas deficient strain of primary skeletal myoblasts transduced with the gene encoding the Fas ligand. These non-tumorigenic cells can be administered to the tumor cells of interest either in vivo at a tumor site or a site from which a tumor has been removed or in vitro. The tumor cells can be rhabdomyosarcoma-derived tumor cells. |
申请公布号 |
AU6964898(A) |
申请公布日期 |
1998.11.11 |
申请号 |
AU19980069648 |
申请日期 |
1998.04.10 |
申请人 |
STANFORD UNIVERSITY |
发明人 |
HELEN M BLAU;ANDREAS HOFMANN |
分类号 |
A61K39/00;A61K48/00;C12N5/077;G01N33/566 |
主分类号 |
A61K39/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|